Wilkins Investment Counsel Inc Novartis Ag Transaction History

Wilkins Investment Counsel Inc

  • $711 Million
  • Q3 2024

A detailed history of Wilkins Investment Counsel Inc transactions in Novartis Ag stock. As of the latest transaction made, Wilkins Investment Counsel Inc holds 188,056 shares of NVS stock, worth $18.3 Million. This represents 3.04% of its overall portfolio holdings.

Number of Shares
188,056
Previous 188,969 0.48%
Holding current value
$18.3 Million
Previous $20.1 Million 7.52%
% of portfolio
3.04%
Previous 3.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $96,896 - $110,372
-913 Reduced 0.48%
188,056 $21.6 Million
Q2 2024

Aug 08, 2024
BUY
$92.57 - $107.37 $114,046 - $132,279
1,232 Added 0.66%
188,969 $20.1 Million
Q1 2024

May 09, 2024
BUY
$95.27 - $108.47 $5.49 Million - $6.25 Million
57,627 Added 44.29%
187,737 $18.2 Million
Q4 2023

Feb 12, 2024
BUY
$92.27 - $101.54 $12 Million - $13.2 Million
130,110 New
130,110 $13.1 Million
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $170,514 - $189,234
-1,800 Reduced 1.36%
130,950 $13.3 Million
Q2 2023

Aug 07, 2023
SELL
$92.52 - $104.91 $181,339 - $205,623
-1,960 Reduced 1.45%
132,750 $13.4 Million
Q1 2023

May 08, 2023
SELL
$80.03 - $92.81 $20,007 - $23,202
-250 Reduced 0.19%
134,710 $12.4 Million
Q4 2022

Feb 07, 2023
BUY
$75.55 - $92.52 $88,771 - $108,711
1,175 Added 0.88%
134,960 $12.2 Million
Q3 2022

Nov 08, 2022
BUY
$74.61 - $87.26 $62,523 - $73,123
838 Added 0.63%
133,785 $10.2 Million
Q2 2022

Aug 08, 2022
SELL
$80.52 - $93.75 $75,125 - $87,468
-933 Reduced 0.7%
132,947 $11.2 Million
Q1 2022

May 10, 2022
BUY
$80.11 - $90.62 $87,319 - $98,775
1,090 Added 0.82%
133,880 $11.7 Million
Q4 2021

Feb 10, 2022
BUY
$79.7 - $88.13 $175,340 - $193,886
2,200 Added 1.68%
132,790 $11.6 Million
Q3 2021

Nov 09, 2021
BUY
$81.78 - $95.14 $196,272 - $228,336
2,400 Added 1.87%
130,590 $10.7 Million
Q2 2021

Jul 30, 2021
BUY
$85.24 - $94.15 $176,873 - $195,361
2,075 Added 1.65%
128,190 $11.7 Million
Q1 2021

May 10, 2021
SELL
$83.5 - $98.47 $60,120 - $70,898
-720 Reduced 0.57%
126,115 $10.8 Million
Q4 2020

Feb 09, 2021
BUY
$78.07 - $94.43 $28,495 - $34,466
365 Added 0.29%
126,835 $12 Million
Q3 2020

Nov 10, 2020
BUY
$82.14 - $91.0 $215,617 - $238,875
2,625 Added 2.12%
126,470 $11 Million
Q2 2020

Aug 10, 2020
BUY
$80.93 - $91.1 $180,069 - $202,697
2,225 Added 1.83%
123,845 $10.8 Million
Q1 2020

May 11, 2020
SELL
$70.67 - $99.01 $65,369 - $91,584
-925 Reduced 0.75%
121,620 $10 Million
Q4 2019

Feb 10, 2020
BUY
$84.35 - $95.37 $44,283 - $50,069
525 Added 0.43%
122,545 $11.6 Million
Q3 2019

Nov 08, 2019
SELL
$85.54 - $94.26 $23,523 - $25,921
-275 Reduced 0.22%
122,020 $10.6 Million
Q2 2019

Aug 09, 2019
SELL
$75.4 - $92.8 $13,195 - $16,240
-175 Reduced 0.14%
122,295 $11.2 Million
Q1 2019

May 10, 2019
SELL
$75.32 - $86.15 $82,851 - $94,765
-1,100 Reduced 0.89%
122,470 $11.8 Million
Q4 2018

Feb 11, 2019
SELL
$73.66 - $82.02 $3,683 - $4,101
-50 Reduced 0.04%
123,570 $10.6 Million
Q3 2018

Nov 09, 2018
SELL
$66.94 - $77.43 $10,041 - $11,614
-150 Reduced 0.12%
123,620 $10.7 Million
Q2 2018

Aug 09, 2018
BUY
$64.91 - $73.36 $360,250 - $407,148
5,550 Added 4.69%
123,770 $9.35 Million
Q1 2018

May 09, 2018
BUY
$70.39 - $84.15 $141,483 - $169,141
2,010 Added 1.73%
118,220 $9.56 Million
Q4 2017

Feb 09, 2018
SELL
$72.33 - $77.64 $107,048 - $114,907
-1,480 Reduced 1.26%
116,210 $9.76 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $7,414 - $7,727
100 Added 0.09%
117,690 $10.1 Million
Q2 2017

Aug 10, 2017
BUY
N/A
117,590
117,590 $9.82 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wilkins Investment Counsel Inc Portfolio

Follow Wilkins Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilkins Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wilkins Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email